Actualités

Sanofi, WhiteLab Genomics, the TaRGeT Laboratory at Nantes University, and Institut Imagine launch WIDGeT to make France a global leader in gene therapy.

MEDETIA, in partnership with Institut Imagine and Inserm Transfert, launches an innovative research program with Ipsen

Isabelle André, Director of Research at Institut Imagine, joins the French Ministry of Higher Education, Research and Innovation as Scientific Director for the Health-Biology sector

Institut Imagine and SimforHealth announce a partnership in rare genetic diseases to support the training of healthcare professionals through digital simulation

Portrait - Hélène Chautard, Director of Innovation and Technology Transfer at Imagine

The Institut Imagine is the winner of the fifth wave of calls for university hospital research projects (RHU5) for the "COVIFERON" project

Qarnot and the Imagine Institute start collaborations to optimize computing power and accelerate research against genetic diseases

Launch of the Medtech Generator & Accelerator program developed by Institut du Cerveau, Institut Imagine and Institut de la Vision

AtmosR, Medetia and Institut Imagine launch collaboration to develop a treatment for Ondine syndrome

Portrait - Marc Chevalier, Head of Bioentrepreneurship

A new treatment discovered at Institut Imagine and developed by QED Therapeutics enters clinical trial with a first child with achondroplasia in France

COVID-19: Institut Imagine and Cerba HealthCare are partnering to test for patients likely to develop severe symptoms

Medetia : towards a first treatment of severe ciliopathy in children

Erminia Rubino, business developer at Institut Imagine

Autoimmune and inflammatory diseases associated with primary immune deficiencies: 11 major healthcare players in France commit to accelerating the development of precision medicine